Skip to Main Navigation

Central African Republic COVID-19 Preparedness & Response Additional Financing

Abstract*

The purpose of the Additional Financing is to provide financing to help the government achieve its objective of covering thepopulation over 15 years of age, which represents 52 percent of the population. It will fund the purchase and deployment ofCOVID-19 vaccines that meet Bank’s vaccine approval criteria (VAC) and strengthen relevant vaccination systems that are necessaryfor successful deployment. The country will provide free of cost vaccinations...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prepare for and respond to the threat posed by COVID-19 in the Central African Republic.

Key Details

Project Details

  • P177618

  • Active

  • Mahoko Kamatsuchi

  • Central African Republic

  • Central African Republic

  • January 18, 2022

  • (as of board presentation)

    February 25, 2022

  • N/A

  • US$ 25.50 million

  • Ministry of Health and Population

  • Western and Central Africa

  • 2022

  • US$ 25.50 million

  • N/A

  • N/A

  • June 30, 2024

  • TBD

  • BANK APPROVED

  • P173832

  • March 27, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Grant 25.50

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 25.50
IBRD + IDA Commitment 25.50
Lending Instrument
Grant Amount N/A
Total Project Cost** 25.50

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)

Footnotes

Ratings

IMPLEMENTATION RATINGS

No data available.

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

No data available.